DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Archimed - 1 Prerna Bedi - 1 Sonia Cheema - 1 Eileen Soreng - 1
Top related locs:
London Archimed Staffordshire Bengaluru
Top related orgs:
Instem Plc - 1 SAS - 1 Ichor Management - 1 Archimed - 1 Healthcare - 1 Thomson - 1

Search resuls for: "Archimed"


2 mentions found


☆ UK's Instem shares pop on $257 mln take-private deal from French firm
  + stars: | 2023-08-30 | by ( ) www.reuters.com   time to read: +1 min
Aug 30 (Reuters) - Shares in Instem Plc (INS.L) soared over 39% on Wednesday after the British life sciences software company agreed to a take-private deal with French private equity firm Archimed SAS for 203 million pounds ($256.5 million). Under the terms of the deal with Ichor Management, a company controlled by Archimed, each Instem shareholder will get 833 pence in cash, representing a premium of 41% to the stock's last close. The offer, which Instem's board recommended shareholders accept, caps multiple rejected proposals from Archimed since March. Healthcare-focused investment firm Archimed has more than 8 billion euros of assets under management and investments in 32 healthcare companies. ($1 = 0.7916 pounds)Reporting by Prerna Bedi in Bengaluru; Editing by Sonia Cheema and Eileen SorengOur Standards: The Thomson Reuters Trust Principles.
Persons: Archimed, Prerna Bedi, Sonia Cheema, Eileen Soreng Organizations: Instem Plc, SAS, Ichor Management, Archimed, Healthcare, Thomson Locations: London, Archimed, Staffordshire, Bengaluru
☆ Warburg Pincus Cashes Out of Polyplus in Lucrative Exit
  + stars: | 2023-04-05 | by ( Maria Armental | ) www.wsj.com   time to read: 1 min
Warburg Pincus notched a hefty gain on its 2020 investment in gene-therapy technology company Polyplus-transfection SA, the latest in a string of healthcare transactions with big payoffs for the private-equity firm. Warburg Pincus stands to make a more-than fourfold return on its initial investment through a sale to strategic buyer Sartorius AG for about €2.4 billion, or roughly $2.62 billion, according to people familiar with the deal announced last week. Polyplus co-owner ArchiMed, a European healthcare investment specialist, could reap a much greater gain as it first backed the company in 2016 at a valuation of less than €10 million, according to a person familiar with the deal.
0 next >>
Total: 2